Print this page    •   Back to Web version of article

The Body Covers: The 9th Conference on Retroviruses and Opportunistic Infections

The 9th Conference on Retroviruses and Opportunistic Infections
Washington State Convention and Trade Center, Seattle, Washington

February 24-28, 2002

The Body Covers:
The 9th Conference on Retroviruses and Opportunistic Infections
Washington State Convention and Trade Center, Seattle, Washington

February 24-28, 2002


The Body's Conference Summaries
Day One
Monday,
February 25
Day Two
Tuesday,
February 26
Day Three
Wednesday,
February 27
Day Four
Thursday,
February 28

Immune Reconstitution and Immunologic Responses to Antiretroviral Therapies: Implications for Therapeutic Strategies

Antiretroviral Chemotherapy: New Agents

Opportunistic Infections and Complications of Antiretroviral Therapy

IL-2 and Other Forms of Immunotherapy

Treatment Interruption

Antiretroviral Chemotherapy: Combination Therapy, Drug Resistance, and Treatment Interruption

Controversies in Antiretroviral Therapy

Adherence to Therapy

Resistance to Antiretroviral Chemotherapeutic Agents

Switch Studies/Treatment of Lipodystrophy Syndromes

New Insights Into Mechanisms of HIV-1 Resistance to Reverse Transcriptase Inhibitors

Treatment of Patients With Drug-Resistant Virus

Antiretroviral Chemotherapy: Pathogenesis of Primary HIV Infection

Pediatric/Maternal-Fetal HIV Infection and Issues in HIV-Infected Women

Antiretroviral Chemotherapy in Drug-Naive Patients

Pharmacokinetics of Antiretroviral Drugs

Late Breakers II

Selected Highlights From Retrovirus



The Body's next-day conference summaries have been reported exclusively by some of the most outstanding HIV specialists in the U.S.A.: Brian A. Boyle, M.D., J.D.; Cal Cohen, M.D., M.S.; Edwin DeJesus, M.D.; Keith Henry, M.D.; Mark Holodniy, M.D., F.A.C.P., C.I.C.; Matthew R. Leibowitz, M.D.; Andrew T. Pavia, M.D.; Paul E. Sax, M.D.; Pablo Tebas, M.D.; and Benjamin Young, M.D., Ph.D.

Funding for this conference coverage at The Body is provided, in part, by unrestricted educational grants from Boehringer Ingelheim Pharmaceuticals and GlaxoSmithKline.


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement




This article was provided by TheBodyPRO.com. Copyright Body Health Resources Corporation. All rights reserved.

You can find this article online by typing the following address into your Web browser:
http://www.thebody.com/content/art15104.html

Please Note: Knowledge about HIV changes rapidly. Note the date of this article's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this article.

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider.